5don MSN
Top cardiologist reveals the blood test that predicts heart attacks (and it’s not cholesterol)
A simple blood test measuring C-reactive protein (CRP) can predict heart attack risk, even in seemingly healthy individuals.
The use of point-of-care testing for C-reactive protein to guide treatment lessened the use of antibiotics for COPD exacerbations without worsening clinical outcomes, according to a study published in ...
This study demonstrated that the rate of antibiotic prescribing and referral to radiography could be reduced by the introduction of POCT for CRP. This reduction was most likely obtained without ...
Throughout the study period, people receiving CRP testing were 20% less likely to be prescribed antibiotics for their exacerbations (57% vs 77.4%). When people with COPD experience exacerbations, 3 ...
Newspoint on MSN
Cardiologist says test tells if you're risking heart attack - and it's not cholesterol
A cardiologist has explained a key test people should take to predict if they're at risk of a heart attack - and it's not ...
Nov. 15 -- A new blood test that is said to predict heart attack risk better than the cholesterol test has generated a lot of excitement among heart specialists and speculation in news reports that it ...
Antibiotic prescribing in primary care practice for patients with COPD exacerbations is generally based on clinical features only, which are subjective and suboptimal for identifying patients who will ...
Ultra-processed foods make up the bulk of U.S. diets, and new research links high intake to inflammation, a predictor of ...
A new blood test that may be a better predictor of heart disease and stroke than cholesterol measures catapulted into the headlines recently after a study in the New England Journal of Medicine. The ...
As health-care workers around the world will attest, infections are extremely common in children in primary care and ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global C-reactive protein test market since 2018 and the market is poised to grow by USD 110.41 million during 2019-2023, progressing at a ...
Background: Point of care testing for C-reactive protein (CRP) has shown promise as a measure to reduce unnecessary antibiotic prescribing in respiratory tract infections (RTI), but its use in primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results